fda-guideline-search
Veto GatesRequired pass for any deployment consideration
| Dimension | Result | Detail |
|---|---|---|
| Scientific Integrity | PASS | The legacy audit did not indicate that retrieval outputs were presented as unsupported findings. |
| Practice Boundaries | PASS | Practice boundaries held because the package remained focused on source handling, lookup, or structured evidence use. |
| Methodological Ground | PASS | No methodological-grounding issue was recorded for fda-guideline-search in the archived evaluation. |
| Code Usability | PASS | Code usability passed because the search or lookup workflow still exposed a usable entrypoint and output expectation. |
Core Capability88 / 100 — 8 Categories
Medical TaskExecution Average: 83.6 / 100 — Assertions: 18/20 Passed
Search FDA industry guidelines by therapeutic area or topic remained well-aligned with the documented contract in the preserved audit.
The Use this skill for evidence insight tasks that require explicit... scenario completed within the documented Search FDA industry guidelines by therapeutic area or topic boundary.
The Search FDA industry guidelines by therapeutic area or topic path verified the packaged helper command without exposing a deeper execution issue.
The Packaged executable path(s): scripts/main.py scenario completed within the documented Search FDA industry guidelines by therapeutic area or topic boundary.
The preserved weakness for End-to-end case for Scope-focused workflow aligned to: Search FDA industry guidelines by therapeutic area or topic was concentrated in one point: The output stays within declared skill scope and target objective.
Key Strengths
- Primary routing is Evidence Insight with execution mode B
- Static quality score is 88/100 and dynamic average is 83.6/100
- Assertions and command execution outcomes are recorded per input for human review